⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ADMA News
ADMA Biologics, Inc.
$ADMA Shareholder News: ADMA Biologics 29% Stock Drop Leads to Securities Fraud Investigation – BFA Law Encourages Investors with Losses to Act
globenewswire.com
ADMA
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA
accessnewswire.com
ADMA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
accessnewswire.com
ADMA
Form 8-K
sec.gov
ADMA
ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older
globenewswire.com
ADMA
$ADMA Stock Drop Alert: ADMA Biologics Stock Plummeted 29% on News of Channel Stuffing – Investors Notified to Contact BFA Law about its Investigation
globenewswire.com
ADMA
ADMA Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
globenewswire.com
ADMA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
accessnewswire.com
ADMA
ROSEN, A LEADING LAW FIRM, Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA
accessnewswire.com
ADMA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
accessnewswire.com
ADMA